"A common misconception among early-stage founders is that any capital is good capital. They believe that getting in the room with investors is the only finish line that matters."
"When finance optimizes exclusively for speed and scale, it becomes less responsive to the earliest stages of creation. Misaligned capital can compress timelines and limit long-term value."
"Our goal is to create a regulated, transparent environment where patient capital can safely support long-term growth, ensuring equality of opportunity for businesses of all sizes."
"Founders and their executives must navigate the capital markets of today. They must intentionally structure their companies to attract patient, collaborative partners rather than extractive capital."
Early-stage founders often mistakenly believe that any capital is beneficial. Misaligned capital can hinder long-term value and distort decision-making. The financial industry is addressing this through initiatives like the Main Street Growth Act, which aims to create venture exchanges for early-stage companies. Founders should structure their companies to attract patient capital and collaborative partners. A clear exit strategy is essential for aligning investor interests with business growth and ensuring sustainable development.
Read at Entrepreneur
Unable to calculate read time
Collection
[
|
...
]